dalteparin has been researched along with Injuries, Radiation in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with liver metastases from colorectal carcinoma who were scheduled for local ablation by radiotherapy (image-guided high-dose-rate interstitial brachytherapy) were prospectively randomized to receive PTX, UDCA and LMWH for 8 weeks (treatment) or no medication (control)." | 2.79 | Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity. ( Damm, R; Gademann, G; Hass, P; Kropf, S; Mohnike, K; Pech, M; Ricke, J; Sangro, B; Seidensticker, M; Seidensticker, R; Wust, P, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowaliuk, M | 1 |
| Bozsaky, E | 1 |
| Gruber, S | 1 |
| Kuess, P | 1 |
| Dörr, W | 1 |
| Seidensticker, M | 1 |
| Seidensticker, R | 1 |
| Damm, R | 1 |
| Mohnike, K | 1 |
| Pech, M | 1 |
| Sangro, B | 1 |
| Hass, P | 1 |
| Wust, P | 1 |
| Kropf, S | 1 |
| Gademann, G | 1 |
| Ricke, J | 1 |
| Liu, CY | 1 |
| Yim, BT | 1 |
| Wozniak, AJ | 1 |
| Izzedine, H | 1 |
| Cluzel, P | 1 |
| Deray, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity After Brachytherapy of Liver Metastases From Colorectal Carcinoma, Assessed in a Prospective Randomised Trial[NCT01149304] | Phase 2 | 22 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dalteparin and Injuries, Radiation
| Article | Year |
|---|---|
Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Enoxaparin; Female; Humans; Liver Neop | 2014 |
3 other studies available for dalteparin and Injuries, Radiation
| Article | Year |
|---|---|
Systemic administration of heparin ameliorates radiation-induced oral mucositis-preclinical studies in mice.
Topics: Animals; Disease Models, Animal; Enoxaparin; Heparin; Humans; Injections, Subcutaneous; Mice; Mice, | 2018 |
Anticoagulation therapy for radiation-induced myelopathy.
Topics: Anticoagulants; Bone Neoplasms; Enoxaparin; Female; Humans; Lung Neoplasms; Middle Aged; Muscular Di | 2001 |
Renal radiation-induced arterial stenosis.
Topics: Adult; Angioplasty, Balloon; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hodgkin Disease; Hu | 2007 |